Glenmark Pharmaceuticals fundamental analysis
GLENMARK
2317.9
15.00 (-0.64%)Last updated on 21 Aug, 2026 | 15:56 IST
Free Demat with Zero AMC*
Open a Free Demat Account
+ Free 1st Year AMC
+ Free 1st Year AMC
Glenmark Pharmaceuticals Score Card
Price
Expensive
Growth
Poor
Quality
Good
Management
Average
On its scorecard, Glenmark Pharmaceuticals reflects: Price – Expensive, Growth – Poor, Quality – Good, and Management – Average. Together, these indicators provide a structured view of the company’s fundamentals.
Glenmark Pharmaceuticals Associated Pages
- Glenmark Pharmaceuticals
Share Price - Glenmark Pharmaceuticals
Share Price chart - Glenmark Pharmaceuticals
Technical Analysis - Glenmark Pharmaceuticals
Peer Comparison - Glenmark Pharmaceuticals
Share Price History - Glenmark Pharmaceuticals
Dividend - Glenmark Pharmaceuticals
Board of Directors - Glenmark Pharmaceuticals
Shareholding Pattern
Open Your Free
Demat Account Now!
AMC for First Year
Auto Square Off Charges
Open a Free Demat Account
+ Free 1st Year AMC
+ Free 1st Year AMC
13 Lakh+ Clients
Expert-Backed
Premium Tools

Open Your Free
Demat Account Now!
AMC For First Year
Account Opening Fee
Open a Free Demat Account
+ Free 1st Year AMC
+ Free 1st Year AMC
13 Lakh+ Clients
Expert-Backed
Premium Tools
Invest in GLENMARK
Account Opening Fee
AMC for 1st Year
Auto Square Off Charges
Call & Trade
Open a Free Demat Account
+ Free 1st Year AMC
+ Free 1st Year AMC